Importantly, a combination of anti-C1q and anti-dsDNA antibodies and/or serum levels of complements C3 and C4 leads to an increase of the specificity but decrease of the sensitivity for identification of SLE patients with active diseases and LN. Here, C3 is linked to lobular neoplasia.